FIELD: pharmacology.
SUBSTANCE: in particular, invention relates to a compound represented by the following general formula (I):
[wherein Ar1 is 2-methoxy-4-(2-pyridylmethoxy)phenyl, etc. and Ar2 is 1H-indole-6-yl group, etc.] or to salt thereof.
EFFECT: increased efficiency of treatment.
19 cl, 4 dwg, 1 tbl, 112 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PYRAZOLE DERIVATIVES | 2013 |
|
RU2682679C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS | 2012 |
|
RU2632870C2 |
TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
TRIAZOLE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND ANTIFUNGAL COMPOSITION | 1996 |
|
RU2146250C1 |
1,2,5-THIADIAZOLE DERIVATIVES OF INDOLYLALKYL-PYRIMIDINYL-PIPERAZINES AND PHARMACEUTICAL COMPOSITION BASED ON THESE COMPOUNDS | 1996 |
|
RU2165420C2 |
PHENYLCARBAMATES AND USE THEREOF AS ENZYME INHIBITORS OF HYDROLASES OF FATTY ACID AMIDES (FAAH) AND DOPAMINE RECEPTOR D3 (D3DR) MODULATORS | 2014 |
|
RU2693457C2 |
PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
CYNNAMIDE COMPOUND | 2005 |
|
RU2361872C2 |
Authors
Dates
2017-07-19—Published
2012-04-11—Filed